Is 16:8 Intermittent Fasting a Weight Loss Tool or a Health Cure?
September 21, 2026
Why Endangered Trapdoor Spiders Are Key to Conservation Success
What to Ask Before Choosing an Online GLP-1 Weight-Loss Clinic
New AI Tool Predicts Long-Term Breast Cancer Recurrence Risk After Treatment
Unlock Lean Muscle and Brain Power: Why Creatine is Worth Considering
What's New?
Understanding Predator Control: Timing Matters in New Zealand's Ecosystems
September 14, 2026
Intensive Blood Pressure Control Linked to 15% Lower Dementia Risk
September 7, 2026
Must Reads
More on medicalnewscorner
FDA approves Vertex’s non-opioid painkiller, first new kind of pain medicine in decades
January 30, 2025
The FDA has approved Vertex Pharmaceuticals' non-opioid painkiller Journavx, marking the first new type of pain medicine approved in decades and offering an alternative to opioids without the risk of addiction.
The key to healthy aging? Exercise might be the answer
January 30, 2025
A recent study published in the Canadian Medical Association Journal explores the wide-ranging health benefits of physical activity for older adults, highlighting how exercise reduces mortality, improves cognitive function, and enhances quality of life — yet remains widely underprescribed in clinical care.
Muvalaplin shows promise in lowering Lp(a) levels in clinical trial
November 19, 2024
A clinical trial testing muvalaplin, a novel oral medication, demonstrated safe and effective reduction of high lipoprotein(a) levels by up to 85.5%, according to late-breaking science presented at the American Heart Association's Scientific Sessions 2024.